News
We're providing £1.55m through our Virtual Biotech programme to carry out the first clinical trials to see if HER-096 is safe for people with Parkinson’s and to start exploring its potential benefits.
Parkinson's UK is funding researchers to develop a potential set of drugs against a new target for people with Parkinson's.
‘I Hear You’, a soundscape of the unheard world of young onset Parkinson’s supported by Parkinson’s UK, was premiered at Bloomsbury Studio, London on Tuesday 11 June.
Research co-funded by Parkinson’s UK finds a new way to potentially improve diagnosis and monitoring of Parkinson’s.
We’ve supported the principle that everyone in Scotland who needs it should have a legal right to palliative care. However, the new law would need additional funding and to be on the right terms for people with Parkinson’s and their families.
We're providing £1.6m through our Virtual Biotech programme to develop a potential new treatment targeting mitochondria to protect brain cells in Parkinson's patients.
A partnership involving Parkinson’s UK has been recognised at the Made with Patients awards, organised by Patient Focused Medicines Development.
We briefed MPs ahead of a parliamentary debate on mental health support for people living with long-term health conditions.
The UK government wants to reform support for people who live with long-term conditions, like Parkinson’s. We want to hear your views on the plans.
Parkinson's UK and Everyone Active have been awarded the Sport, Travel and Leisure partnership award winners at the 2024 Third Sector Business Charity Awards.